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OBJECTIVE: The effects of sevoflurane general anesthesia and bupivacaine selective spinal anesthesia on QT
dispersion (QTd) and corrected QT (QTc) interval were investigated.
METHODS AND MATERIALS: This prospective, randomized, double-blind study was conducted between July and
September 2009 in the Urology and General Surgery operating rooms. Forty ASA I–II patients undergoing
noncardiac surgery were randomized into two groups: Group R (n = 20) and Group V (n = 20). In Group R, 5 mg
bupivacaine was administered into the spinal space. Anesthesia induction in Group V was established with
sevoflurane + 0.1 mg/kg vecuronium using the maximum vital capacity technique. Anesthesia was maintained with
2–3% sevoflurane + 50% N2O/O2 inhalation. All patients were tested with a 24-hour Holter ECG device. QT, QTc, and
QTd intervals were measured using 12-lead ECG records at 1 and 3 minutes during preinduction, postinduction,
postincision and postextubation periods. Mean arterial pressure (MAP), heart rate and ECG records were measured
simultaneously.
RESULTS: None of the patients displayed arrhythmia. There was no significant difference between the groups with
regard to QTd values (p.0.05). However, QTc was longer in Group V than in Group R after the induction of
anesthesia at 3 minutes, after the intubation at 1 and 3 minutes, and after the incision at 1 and 3 minutes. MAP and
heart rate were generally higher in Group V (p,0.05).
CONCLUSION: Although Volatile Induction and Maintenance of Anesthesia (VIMA) with sevoflurane might prolong
the QTc interval and did not result in arrhythmia, selective spinal anesthesia with bupivacaine was not associated
with alterations in the QT interval or arrhythmia.
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INTRODUCTION
The effects of anesthetics on the cardiovascular system
have a complicated character, and almost all of the effects
lead to dose-related myocardial depression and decreases in
heart rate and arterial pressure. In anesthesia practice,
individual responses of patients against procedures such as
induction, intubation, and surgical stimulation are influ-
enced by many factors, including preoperatively used
drugs, anesthesia type, preferred anesthetic agents, and
the autonomic nervous system.1,2
Many of the anesthetics used in anesthesia practice
interact with the QT interval. Depolarization and repolar-
ization of the myocardium take place within the QT interval.
Varying QT intervals have been associated with hetero-
geneous repolarization and ventricular arrhythmias.3,4
Therefore, prolonged QT intervals may be harmful, at least
in cases with myocardial pathologies, necessitating anesthe-
sia methods that do not influence the QT interval.5
QT dispersion (QTd) is defined as the difference between
the longest and shortest QT intervals in 12-lead ECG. QTd is
particularly recognized as the indirect measurement of the
repolarization and has been associated with complex
ventricular arrhythmias.3
Several studies investigating the effects of sevoflurane on
QT, QTd, and QTc have revealed differing results.6,7 We
found no study investigating the effects of selective spinal
anesthesia on QT interval and arrhythmia. In the present
study, we aimed to investigate the effects of selective spinal
anesthesia with bupivacaine and sevoflurane inhalation
anesthesia (VIMA) on QT interval, QTd, QTc, QTcd, and
arrhythmia.
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METHODS AND MATERIALS
Our prospective, randomized, double-blind study was
conducted between July and September 2009 in the Urology
and General Surgery clinics. Following the approval of the
ethics committee and collection of informed consent, 40
ASA I–II patients 18–65 years of age who were scheduled to
undergo urologic intervention or inguinal hernia surgery
were included in the study. Patients with a history of a
chronic obstructive lung disease, cardiovascular disease,
electrolyte imbalance, diabetes mellitus, chronic alcoholism,
idiopathic, congenital, or acquired prolonged QT syndrome,
chronic drug use, or a Mallampati score $2 were excluded
from the study.
Hemodynamic monitoring included mean arterial pres-
sure (MAP), heart rate (HR), and peripheral oxygen
saturation (SpO2). In addition, 24-hour Holter ECG was
performed on all patients (Delmar Impresario, USA) to
maintain a continuous ECG record.
The cases were randomly split into two groups: Group V
(n = 20) and Group R (n = 20). The allocation sequence was
generated by a table of random numbers. None of the cases
received premedication. Anesthesia induction in Group V
was established using the maximum vital capacity techni-
que with 8% sevoflurane + 50% N2O/O2. After the
achievement of neuromuscular block with 0.1 mg kg21
vecuronium, endotracheal intubation was performed.
Anesthesia was maintained with 2–3% sevoflurane + 50%
N2O/O2 inhalation.
In Group R, selective spinal anesthesia was performed by
delivering 5 mg 0.5% hyperbaric bupivacaine to the L4–L5
space via the midline approach to the patients in the sitting
position. A local anesthetic agent was administered within
20 seconds without aspiration of the CSF, and the patients
were kept sitting at a 45˚ angle until the achievement of T10
anesthesia (maximum 10 minutes). Sensory block was
evaluated with the pinprick test, while motor block was
assessed with the Bromage scale. Surgery was allowed
when the sensory block reached the T10 level.
The study was designed to examine the following: to
elevate the crystalloid infusion speed to 15 mg/kg/h when
MAP dropped below 30% and persisted at that level for
more than 30 seconds; to carry out 5 mg/kg/h colloid
infusion upon persistence of the hypotension for 15 minutes;
to apply 5 mg ephedrine when the cases failed to normalize
after another 15 minutes; to increase the anesthesia depth
when MAP increased above 30%; and to administer 0.1 mg
nitroglycerine relative to the MAP. We also planned to
deliver 0.5 mg atropine when the HR dropped below 50.
We did not use anticholinesterase or opioid therapy in
case they would influence the QT and QTc intervals.
Data analyses of both of the groups were performed at the
times noted in Table I. MAP, HR, and SpO2 values were
recorded. ECG analyses were carried out.
ECG records were examined with a Holter monitor by the
same cardiologist. The QT interval was analyzed through-
out the whole operation. The QT interval was recognized as
the duration between the beginning of the QRS complex and
the end of the T wave in the ECG. The mean QT interval was
calculated manually, and the QT interval measurement was
corrected for heart rate using the Bazett formula (12).
QTc(sn) = QT/
ﬃﬃﬃﬃﬃﬃﬃ
RR
p
QTd(sn) = QTmax 2 Qtmin
QTcd(sn) = QTcmax 2 Qtcmin
QTc(sn): corrected QT interval, QTd(sn): QT dispersion
time, QTcd(sn): corrected QT dispersion time, QT max:
maximum QT interval, QT min: minimum QT interval.
The study was conducted with the significance level set at
alpha = 0.05 and beta = 0.8 power. The study included 40
subjects (n1 = n2 = 20). No patient was excluded from the
study. The power, based on the QTc values of the groups,
was found to be 0.83.
The data obtained in the present study were evaluated
with SPSS version 12 (SPSS, Chicago, IL). We used the chi-
square test for dependency between the variables, the
Mann-Whitney U test for comparisons between groups,
and the Wilcoxon signed-rank test for comparisons within
the groups. The Mann-Whitney U test was used for all
comparisons of the demographic characteristics with the
exception of gender. Gender was compared using the chi-
square test. A p value ,0.05 was considered significantly
significant.
RESULTS
No significant differences in demographic characteristics
were found between the groups (Table 2).
The HR values did not significantly differ within either
group. However, the Group V HR values were high after the
induction (p: 0.02) (Figure 1).
The MAP values were not significantly different within
groups, but the Group R MAP values were lower than the
Group V values at all measurement time points. However,
none of the cases demonstrated a need for therapeutic
intervention for blood pressure changes (Figure 2).
When compared within groups, the QTd, QTc, and QTcd
values displayed no significant differences at any of the
Table 1 - Measurement phases in VIMA and spinal
anesthesia.
Phases Spinal VIMA
Phase 1
(preinduction)
At 0 minutes At 0 minutes
Phase 2 At 1 minute Sevoflurane at 1 minute
Phase 3 At 3 minutes Sevoflurane at 3 minutes
Phase 4 At 4 minutes Vecuronium at 1 minute
Phase 5 At 6 minutes Vecuronium at 3 minutes
Phase 6 At 7 minutes First minute of intubation
Phase 7 At 9 minutes Third minute of intubation
Phase 8 First minute of incision First minute of incision
Phase 9 Third minute of incision Third minute of incision
Phase 10 First minute of surgical
end
First minute of extubation
Phase 11 Third minute of surgical
end
Third minute of extubation
Table 2 - Demographic data (mean¡SD).
Group R (n = 20) Group V (n = 20) p
Age (years) 42.9¡11.88 (18–65) 44.5¡10.47 (26–64) 0.567
Weight (kg) 80.36¡10.35 78.40¡9.93 0.456
Height (cm) 168.46¡8.42 167.36¡9.23 0.632
Gender (F/M) 12/18 14/16 0.602
ASA (I/II) 12/18 13/17 0.793
Operation length
(min.)
33 (17–64) 40 (20–76) 0.088
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measured time points. Intergroup comparisons exhibited a
high QTd at 3 minutes after extubation in Group V. QTc was
significantly higher in Group V than in Group R at 3 minutes
after the induction, 1 and 3 minutes after the intubation, and
1 and 3 minutes after the incision (Figures 3 and 4) (p,0.05).
QTcd values were significantly higher in Group V at 1
and 3 minutes after the induction, 1 and 3 minutes after the
extubation, and 1 and 3 minutes after the incision (Figure 5).
DISCUSSION
Several conditions, such as diabetes mellitus, arrhythmia,
ischemic cardiac diseases, pulmonary disease, uremia,
electrolyte and acid/base disorders, and prolonged QT
syndrome, and the drugs used in their treatment, such as
antihypertensives, beta-blockers, antidiabetics, and opioids,
are known to influence the QT interval.8
A prolonged QT interval should be considered an
important symptom because it can lead to serious ven-
tricular arrhythmias.8 It is not easy to differentiate the
underlying cause of changes in QT interval among factors
such as delivered pharmaceutical agents, drug interactions,
and sympathetic activation occurring upon laryngoscopy
and intubation.1
Michaloudis et al. applied VIMA with sevoflurane and
isoflurane and found that isoflurane prolonged the QTc
interval but did not change QTd or QTcd, whereas
sevoflurane did not affect those three parameters; overall,
they determined that sevoflurane was a good agent.9 Guler
et al. showed that sevoflurane, isoflurane, and halothane
prolonged QTd and QTcd in patients who had no congenital
heart disease. However, they found no statistically signifi-
cant difference between the agents and concluded that those
anesthetic agents caused myocardial repolarization abnorm-
alities by increasing QTcd. In the same study, prolonged
QTcd was found to have the potential to play a role in
arrhythmias observed among people receiving anesthesia
who had no cardiovascular disease. In light of the fact that
those agents can prolong QTcd further, Guler et al. noted
that this parameter could be used during the development
of new agents.10
Saarnivaara et al.5 reported that changes in ventricular
repolarization might cause a prolonged QTc interval in
cases where anesthetic agents have induced sympathoa-
drenal hyperactivity. Prolonged QTc interval has been
reported to show autonomic nervous system imbalance in
the heart, thereby lowering the ventricular fibrillation and
leading to ventricular arrhythmia.11 Abe et al.6 reported
ventricular tachycardia development under sevoflurane and
N2O anesthesia. A study using the single-breath induction
technique with sevoflurane found marked prolongation of
and increased development of arrhythmia in the QT
interval.12 A study comparing 1 MAC sevoflurane and
desflurane reported a prolonged QTc interval and increased
QTd upon delivery of each of those two agents.13 Karagoz et
al.14 conducted a study to analyze the effects of halothane,
isoflurane, and sevoflurane, in which they reported no
changes in the QTc interval as a result of 2% sevoflurane
and 50% O2 + 50% N2O. In the current study, QTc was
higher in Group V than in Group R at every measured time
point, and significant differences were identified during
times of intense perioperative sympathetic activation,
particularly at 3 minutes after the induction and 1 and
3 minutes after the incision (p,0.05). Given the previous
finding claiming the presence of a direct relationship
between plasma catecholamine levels and QT interval, it is
probably no coincidence that QTc was markedly prolonged
during times of intense sympathetic activation.15
In the present study, a QTc of 506 ms, recognized as the
upper limit of the normal QTc interval, was not reached in
any of the cases. Again, no prolonged QTc exceeded the
basal value more than 75 ms.
Figure 1 - Heart rates in the two study groups (beats per minute).
Figure 2 - MAP values in the two study groups (mmHg).
Figure 3 - QTc values in the two study groups (seconds).
Figure 4 - QTd values in the two study groups (milliseconds).
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Although some studies have noted that prolonged QTc
contributes to the development of cardiac arrhythmias, 5,20
similar to the results of the study of Saarnivaara et al.,5 we
did not identify a relationship between the prolonged QTc
duration and the development of arrhythmia in the present
study. As in our study, this study found that heart rate was
generally high during the periods of prolonged QTc, and
the authors attributed this to perioperative anxiety and
elevated sympathetic activity. In view of the fact that
amiodarone, a type III antiarrhythmic agent, prolongs the
QT interval while having no influence over QTd or
ventricular extrasystole formation, we believe that the
electrophysiologic mechanism playing a part in arrhythmia
development should have been clearly identified.17
The normal range of QTd is 300–600 ms.18 QTd
demonstrates the regional homogeneity of ventricular
myocardial cells during repolarization and reflects the
physiologic desynchronization of myocardial excitability.
A prolonged QTd interval is an important determinant of
ventricular arrhythmias and sudden cardiac deaths.
Moreover, while some studies note that QTd values longer
than 65 ms are important in ventricular tachycardia
etiology, there are also studies that describe 70 ms as a
normal value. In a detailed study on this subject, QTd was
found to provide reliable data on prognosis estimation and
foreknowledge of cardiac problems stemming from myo-
cardial repolarization abnormalities. However, the same
study recommended that a marked repolarization abnorm-
ality be considered in cases with a QTd value above 100 ms.8
In the current study, although QTd was longer in Group V
at 3 minutes after the extubation (phase 10), it was not
higher than 57 ms in any of the cases. In view of the
variation from the initial phases in the VIMA and spinal
anesthesia groups, there was no statistically significant
difference with regard to the QTc, QTd, and QTcd values.
A multicenter study conducted on 17,000 patients in 2000
investigated the effects of spinal anesthesia on arrhythmia
and found that 70.2% of the cases displayed tachycardia,
bradycardia or arrhythmia. Most of those arrhythmias were
of spontaneous and remitting minor types. Additionally,
30.3% showed sinus arrhythmia, whereas 27.2% and 13.8%
exhibited premature beat and bradycardia, respectively.19
Moreover, another prospective spinal anesthesia study on
40,460 patients reported the rate of bradycardia incidence
before cardiac arrest as 6.4/10.000. All of the cases that
experienced arrest responded to resuscitation. In that study,
the formation of varying degrees of cardiac blocks were
noted.20 In contrast to that study, our study preferred
selective spinal anesthesia, and its influence over arrhyth-
mia was not determined. We believe that the difference
between the studies may be due to the different methods
applied.
Bupivacaine is an anesthetic agent that is frequently used
in current anesthesia practice. Although most of the toxic
reactions are associated with high plasma concentrations of
bupivacaine, cases of mortality and morbidity have been
reported, even at low doses. Systemic complications
exhibiting reduced cardiac output and changes in the
central nervous system have been observed, even at a
1 mg/ml plasma concentration.21 Hotverd et al. conducted a
study showing that bupivacaine at a 2 mg/ml plasma
concentration had a negative inotropic effect and prolonged
cardiac conduction. That study also implicated bupivacaine
in re-entry arrhythmias. Bupivacaine is 4 times more
effective than lidocaine and causes cardiovascular and other
systemic toxicities 4–17-times more frequently than lido-
caine.22 Studies with bupivacaine have reported supraven-
tricular tachycardia, atrioventricular block, early ventricular
beats in various forms, QRS changes, and fatal ventricular
fibrillation. Moreover, independent of dose, the most
common rhythm abnormality in hypoxia and acidosis is
bradycardia with a wide QRS complex.
In animal studies, bupivacaine, etidocaine, mepivacaine,
and lidocaine delivered as an i.v. bolus and infusion have
been reported to cause an increase in the area below the T
wave, prolong the QT interval, and induce the formation of
a U wave following the T wave; these effects were more
significant in the etidocaine and bupivacaine groups. The
effects of those agents over the temporal dispersion of the
effective refractory period were reported as 37.4 ms in
lidocaine, 48.3 ms in mepivacaine, 92.5 ms in etidocaine, and
98.1 ms in bupivacaine. Moreover, a relationship between
prolongation of the effective refractory period and ventri-
cular arrhythmia was also noted.22
Decreases in systemic blood pressure can lead to changes
in heart rate and cardiac rhythm alterations.2 However,
hypotension during anesthesia is described as a reduction of
the basal value of arterial pressure below 20%. In the current
study, while none of the groups demonstrated changes
exceeding that limit in blood pressure or heart rate values,
MAP and HR were significantly higher in Group V than in
Group R in measurements performed after intubation,
incision, and extubation. Lowrie et al. found a considerable
increase in HR, SAP, and DAP parallel to the elevations in
plasma norepinephrine and epinephrine concentrations.
Moreover, they reported a significant rise in epinephrine
level and heart rate within the first five minutes of
extubation. In the present study, elevation in the heart rate
during intubation and extubation in the VIMA group was
consistent with the results of the study of Lowrie et al.15
In our study, MAP values showed a significant increase in
the VIMA group compared with the spinal group. This
result is consistent with the sympathetic discharge results
obtained during the intubation and extubation phases in the
studies of Tanaka et al. and Lowrie et al.15,24
Selective spinal anesthesia had a greater influence over
QT and hemodynamic parameters when compared with the
VIMA with sevoflurane alone. If a medication is delivered
to block the adrenergic discharge, the cardiac effects of
VIMA with sevoflurane can be prevented. Moreover,
considering that our study was performed only on ASA I–
II patients, we believe that further studies of arrhythmia
should be conducted on patients with higher risk and that
proper anesthesia protocols should be established.
Figure 5 - QTcd values in the two study groups (milliseconds).
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Nevertheless, selective spinal anesthesia has not been
compared with VIMA with regard to QTd, QTc, QTcd,
and arrhythmia incidence.
In conclusion, although VIMA with sevoflurane might
prolong the QTc interval and did not result in arrhythmia,
selective spinal anesthesia with bupivacaine was not
associated with alterations in the QT interval or arrhythmia.
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